Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2018

Protocol for a randomised trial of higher versus lower intensity
patient–provider communication interventions to reduce
antibiotic misuse in two paediatric ambulatory clinics in the USA
Kathy Goggin
University of Missouri - Kansas City

Andrea Bradley-Ewing
Children’s Mercy Hospitals and Clinics, Kansas City

Angela L. Myers
University of Missouri - Kansas City

Brian R. Lee
University of Missouri-Kansas City

Emily A. Hurley
Children’s Mercy Hospitals and Clinics, Kansas City

See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Goggin, Kathy; Bradley-Ewing, Andrea; Myers, Angela L.; Lee, Brian R.; Hurley, Emily A.; Delay, Kirsten B.;
Schlachter, Sarah; Ramphal, Areli; Pina, Kimberly; Yu, David; Weltmer, Kirsten; Linnemayr, Sebastian; Butler,
Christopher C.; and Newland, Jason G., ,"Protocol for a randomised trial of higher versus lower intensity
patient–provider communication interventions to reduce antibiotic misuse in two paediatric ambulatory
clinics in the USA." BMJ Open. 8,. e020981. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6965

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Kathy Goggin, Andrea Bradley-Ewing, Angela L. Myers, Brian R. Lee, Emily A. Hurley, Kirsten B. Delay, Sarah
Schlachter, Areli Ramphal, Kimberly Pina, David Yu, Kirsten Weltmer, Sebastian Linnemayr, Christopher C.
Butler, and Jason G. Newland

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/6965

Open Access

Protocol

Kathy Goggin,1,2,3 Andrea Bradley-Ewing,1 Angela L Myers,2,4 Brian R Lee,1,2
Emily A Hurley,1 Kirsten B Delay,1 Sarah Schlachter,1 Areli Ramphal,1
Kimberly Pina,1 David Yu,5 Kirsten Weltmer,2 Sebastian Linnemayr,6
Christopher C Butler,7 Jason G Newland8

To cite: Goggin K, BradleyEwing A, Myers AL, et al.
Protocol for a randomised
trial of higher versus lower
intensity patient–provider
communication interventions
to reduce antibiotic misuse
in two paediatric ambulatory
clinics in the USA. BMJ Open
2018;8:e020981. doi:10.1136/
bmjopen-2017-020981
►► Prepublication history and
additional material for this paper
are available online. To view
please visit the journal (http://
dx.doi.org/10.1136/bmjopen-
2017-020981).

Received 5 December 2017
Revised 22 February 2018
Accepted 5 April 2018

For numbered affiliations see
end of article.
Correspondence to
Dr Kathy Goggin;
kgoggin@cmh.edu

Abstract
Introduction Children with acute respiratory tract
infections (ARTIs) are prescribed up to 11.4 million
unnecessary antibiotic prescriptions annually. Inadequate
parent–provider communication is a chief contributor,
yet efforts to reduce overprescribing have only indirectly
targeted communication or been impractical. This
paper describes our multisite, parallel group, cluster
randomised trial comparing two feasible interventions for
enhancing parent–provider communication on the rate of
inappropriate antibiotic prescribing (primary outcome) and
revisits, adverse drug reactions and parent-rated quality of
shared decision-making, parent–provider communication
and visit satisfaction (secondary outcomes).
Methods/analysis We will attempt to recruit all eligible
paediatricians and nurse practitioners (currently 47) at
an academic children’s hospital and a private practice.
Using a 1:1 randomisation, providers will be assigned to
a higher intensity education and communication skills or
lower intensity education-only intervention and trained
accordingly. We will recruit 1600 eligible parent–child
dyads. Parents of children ages 1–5 years who present
with ARTI symptoms will be managed by providers trained
in either the higher or lower intensity intervention. Before
their consultation, all parents will complete a baseline
survey and view a 90 s gain-framed antibiotic educational
video. Parent–child dyads consulting with providers
trained in the higher intensity intervention will, in addition,
receive a gain-framed antibiotic educational brochure
promoting cautious use of antibiotics and rate their
interest in receiving an antibiotic which will be shared with
their provider before the visit. All parents will complete a
postconsultation survey and a 2-week follow-up phone
survey. Due to the two-stage nested design (parents
nested within providers and clinics), we will employ
generalised linear mixed-effect regression models.
Ethics/dissemination Ethical approval was obtained
from the Children’s Mercy Hospital Pediatric Institutional
Review Board (#16060466). Results will be submitted for
publication in peer-reviewed journals.
Trial registration number NCT03037112; Pre-results.

Strengths and limitations of this study
►► Implements a parent–provider communication in-

tervention based on a previously effective intervention and adapted for feasibility in the US paediatric
ambulatory setting.
►► Works closely with a multicultural group of parents,
providers and other stakeholders to ensure feasibility and appropriateness of intervention components,
study procedures and study materials in Spanish
and English.
►► Adequately powered to detect differences between
the higher and lower intensity interventions, with a
1:1 randomisation of providers to intervention arms
and a target sample of 1600 parents/child dyads.
►► Data on primary outcomes (ie, rates of inappropriate antibiotic prescribing), secondary outcomes (ie,
revisits and adverse drug reactions, shared decision-making, quality of parent–provider communication and satisfaction) and potential covariates will
yield novel insights into the effectiveness of each
intervention.
►► Provider training was limited to one 20 min session
for all providers and one additional 50 min session
for providers in the higher intensity arm.

Introduction
Antibiotic overuse and misuse contribute to
the development of antibiotic-resistant infections that if left unchecked are estimated to
cause 10 million deaths worldwide by 2050.1
In the USA, antibiotic-resistant infections
are responsible for at least 23 000 deaths and
an additional 2 million infections annually.2
Inappropriate antibiotic use also increases
incidence of antibiotic-associated adverse
drug reactions (eg, rash, diarrhoea, nausea
and vomiting), which result in >140 000
emergency department visits every year.3
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(ie, comfort care) plus ‘negative treatment recommendations’ (ie, antibiotics will not help) was associated with the
highest parent satisfaction.18
Current efforts to improve appropriate antibiotic use
have only indirectly targeted parent–provider communication19 20 or have been found to be impractical.21 As
described in several meta-analytic and systematic reviews,
interventions have typically focused on education about
antibiotics for providers or patients.19 20 While many have
been successful in increasing knowledge about antibiotics and nationally antibiotic prescribing has evidenced
modest reductions,8 22 more effective strategies that go
beyond educational targets are needed to reduce overprescribing rates to levels that will have a significant impact.
A limited number of studies have been conducted that
target parent–provider communication or shared decision-making, and they have already produced superior
results.20 Of the communication interventions tested, only
one has directly targeted provider perceptions of parental
expectations alongside antibiotic education and shared
decision-making.23 This study, which employed intensive provider training and a multipage patient–provider
interactive educational booklet, resulted in a significant
decrease in antibiotic use. The intervention, however, was
viewed as burdensome by providers and impractical for
most real-world settings.21 Effective, practical interventions are needed that address provider misconceptions
about parent expectations, facilitate shared-decision
making and improve aspects of communication that are
most likely to increase parental satisfaction.
The goal of this study is to compare two feasible
interventions for enhancing parent–provider communication to reduce the rate of inappropriate antibiotic
prescribing. This study will compare the efficacy of a
higher intensity provider education and communication
skills intervention to a lower intensity provider education
only intervention. We hypothesise that the parent–child
dyads managed by providers trained in the higher intensity intervention will demonstrate superiority to dyads
managed by providers trained in the lower intensity intervention on the primary outcome of rate of inappropriate
antibiotic prescribing, as well as the secondary outcomes
of revisits, adverse drug reactions and parent-rated quality
of shared decision-making, parent–provider communication and satisfaction.
Methods and analysis
Patient and public involvement
In the early planning stages for this study, we conducted
focus groups and individual interviews with clinical, parent,
payer and community stakeholders to assess the viability
and inform the design of the study. We then recruited a
Parent Research Associate who is a core member of our
research team, attends all meetings, contributes to all
decisions about the study and co-leads our Community
Advisory Board (CAB). Our CAB comprises 15 parent,
provider and community stakeholders and is diverse
Goggin K, et al. BMJ Open 2018;8:e020981. doi:10.1136/bmjopen-2017-020981
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The majority of all antibiotic prescribing in the USA
occurs in the outpatient setting where children receive
49 million prescriptions annually.4 Children with acute
respiratory tract infections (ARTIs) receive >70% of
these prescriptions of which 29% are unnecessary (ie,
either to treat a viral illness or an unnecessary broad-spectrum antibiotic).4 Despite some improvements, the most
recent estimates suggest that antibiotics are prescribed
for approximately 50% of ARTIs while it is estimated that
only 27% of ARTIs are caused by bacterial infection.5 As
a result, children are receiving up to 11.4 million unnecessary antibiotic prescriptions annually.5 Strikingly, an
almost identical number was noted in a similar study
conducted 16 years earlier (11.1 million unnecessary antibiotic prescriptions), suggesting there are considerable
gains still to be made in reducing inappropriate use.6
Inappropriate antibiotic prescribing in the ambulatory setting has many causes, but the interaction
between parents/legal guardians (hereafter referred to
as parents) and providers is central. For their part, some
parents still harbour misconceptions that make them
think antibiotics are necessary when they are not.7 Nevertheless, parents generally desire antibiotics for their children only when absolutely necessary8 and do not expect
antibiotics for common colds.9 Instead, parents become
dissatisfied when providers minimise children’s symptoms, fail to acknowledge parents’ appropriate concerns
and/or do not offer a contingency plan if symptoms fail
to resolve.10 11
Despite evidence to the contrary, providers perceive
significant parental pressure for antibiotics and fear
damaging the parent–provider relationship if they withhold prescriptions.12 13 Combined with the ever-increasing
time constraints and focus on parent satisfaction ratings
inherent in modern clinical practice, these beliefs greatly
contribute to ineffective parent–provider communication
about antibiotics. When providers perceive that a parent
expects or hopes for an antibiotic, they are more likely to
prescribe one.14 15 In a study of children with viral ARTIs
where no prescription should have been given, providers
gave a prescription to 52% of parents they believed
were expecting an antibiotic compared with only 9% of
parents who they believed were not expecting an antibiotic.16 Adding to this problem is providers’ mistaken
belief that they can accurately predict parents’ desires.
In fact, providers’ ability to accurately predict parents’
expectation for an antibiotic is significantly worse than
chance at 24%–41% concordance.12 16 Even though
parents rarely state a desire for antibiotics (1% of the
time in clinical recordings), providers report frequent
parent demands for antibiotics.17 Providers also mistakenly believe that meeting perceived parental expectations for antibiotics is necessary for parent satisfaction.13
Parental satisfaction, however, is not related so much to
whether or not they receive an antibiotic but more to the
quality of communication with their provider.10 13 In fact,
a recent observational study demonstrated that the use of
what they termed ‘positive treatment recommendations’
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Trial design, setting and participants
Trial design
A multisite parallel group, cluster randomised trial with
balanced randomisation (1:1) will be performed in three
ambulatory paediatric clinics in the USA. Recruitment
of providers will start in January of 2017 and continue
throughout the study as new providers are hired. Providers
(physicians and nurse practitioners) will be randomly
assigned to training in either the higher intensity or lower
intensity intervention described below. Once providers
have been randomised and trained, eligible parent–child
dyads will be enrolled and exposed to management by
a provider who was trained in one of the interventions.
Recruitment of parent–child dyads will start in March of
2017 and continue through December of 2018. Parents in
both arms will receive education on the pros and cons of
antibiotics for common infections and tips for communicating with their provider. Blinding of providers will not
be feasible in this study; however, parents will be blinded
as they will not be told what study arm their provider is
in, nor informed about differences between the study
interventions. Study team members who conduct chart
review to code appropriateness of antibiotic prescriptions
and code session audiotapes for intervention fidelity will
be blinded. A principal investigator (KG) will monitor
recruitment, retention (bimonthly) and adverse events
(quarterly; blinded to study arm) in this low-risk study.
Adverse events will be collected from parents at 2-week
follow-up, through chart review and spontaneously from
clinic staff. Any protocol modifications will be submitted
for Institutional Review Board review and communicated
to all relevant parties before implementation.
Randomisation
To protect against practice effects (tendency for
providers to have more consistent beliefs and behaviours
within their practice compared with providers in other
practices), we will randomise providers rather than
clinic sites. We did this because the intervention components are not easily transferred between providers
making the risk of contamination a much smaller
threat to validity than practice effects. As detailed below
in the higher intensity provider training section, we
will employ several strategies to reduce the chance of
contamination across study arms. We will use clinic data
on visits among our target population from the past
Goggin K, et al. BMJ Open 2018;8:e020981. doi:10.1136/bmjopen-2017-020981

six months to assign each provider to a large or small
patient volume group. The study statistician will then
stratify the randomisation of providers to ensure each
study arm is balanced across large and small volume
providers and across clinics. The study statistician will
place the intervention group assignment in sealed envelopes labelled with providers’ names. Providers will be
given their envelopes at the conclusion of a brief study
orientation and informed consent meeting and before
completing the baseline assessment.
Setting
Study sites will be an academic medical centre (Children’s Mercy Hospital Primary Care Clinic (CMH
PCC)) and both locations of a private practice (Heartland Primary Care (HPC)). CMH PCC sees a racially
and ethnically diverse group of patients (41% African-American/black, 29% Hispanic, 18% white) from
the Kansas City metropolitan area, of which 73% are
covered by Medicaid. CMH PCC has 38 providers (28
paediatricians and 10 nurse practitioners) and treats
approximately 2100 children with an ARTI that meet
study inclusion criteria yearly. HPC is a community-based private practice with two locations in sub-urban
Kansas City serving a diverse patient population (14%
African-American/black, 16% Hispanic, 75% white;
42% covered by Medicaid). HPC has nine paediatric
providers (six paediatricians and three nurse practitioners) who care for 2000 children that meet study
inclusion criteria annually. Approximately 20% of
parents at study sites are Spanish speaking.
Participants
This study involves providers and parent–child dyads. We
will attempt to recruit all eligible providers at all study
sites (paediatricians, paediatric nurse practitioners;
n=47), defined as those who regularly treat patients that
meet our inclusion criteria. Providers primarily assigned
to administration, urgent care or specialty clinics that
serve complex care patients will not be eligible. We will
conduct brief study orientation and informed consent
meetings to enrol providers during regularly scheduled
clinic meetings or individual contacts.
We will recruit up to 1600 parent–child dyads (see
figure 1). Dyads will be eligible if the patient is between
ages 1 and 5 years (ie, before sixth birthday), presents
with ARTI symptoms (eg, cough, congestion, difficulty
breathing, sore throat, ear ache) and his/her parent
is fluent in English or Spanish. Children will not be
eligible if they have received an antibiotic in the last
30 days, have a concurrent probable bacterial infection (eg, urinary tract infection, soft tissue infections),
known immunocompromising conditions (eg, HIV,
malignancy, solid-organ transplant, chronic corticosteroid use) or factors that make shared decision-making
around prescribing an antibiotic extremely complex,
like children with complex chronic care conditions (eg,
cystic fibrosis),24 or who require hospitalisation during
3
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(ie, three males, seven Latinx (three exclusively Spanish
speaking) and three African-Americans). CAB meetings
will occur every other month during year 1 and twice
yearly in years 2 and 3. All aspect of the study design,
settings, participant burden, materials, procedures, interpretation of data and dissemination of study findings
have and will be informed by the CAB and Community
Research Associate. Study results will be disseminated to
all clinic providers. A parent summary of findings will be
developed and provided to study sites who will be encouraged to post in their facilities and/or mail to parents.
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Schematic diagram of parent–patient dyad participant flow.

the visit. We will include patients with penicillin allergy
as shared decision-making with this group is especially important given more limited treatment options.
Parents or children who have previously participated
in the study will not be eligible to participate again.
Potentially eligible dyads will be identified through
prescreening all appointments and parents will be given
a study flyer on check-in. Potential eligible dyads will be
greeted in the exam room before the provider arrives,
given a short synopsis of the study and offered eligibility screening. If more than one caregiver is with the
child, they will be asked to designate one person who
will complete the informed consent and all assessments.
4

Providers will have no role in identifying potentially
eligible dyads, screening, consenting or data collection.
Trial interventions
Higher intensity intervention
With attention to the feasibility in the US healthcare
system, this intervention will be informed by a series of
evidence-based interventions conducted in the UK and
Europe: Enhancing the Quality of Information-sharing in
Primary care (EQUIP),23 25 Improving the Management
of Patients with Acute Cough Trial (IMPACT),26 27Stemming the Tide of Antibiotic Resistance (STAR)28 29 and
Genomics to combat Resistance against Antibiotics in
Community-acquired LRTI in Europe (GRACE).30
Goggin K, et al. BMJ Open 2018;8:e020981. doi:10.1136/bmjopen-2017-020981
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and lower intensity arms and objectively code use of key
communication strategies using established methods that
we have successfully employed in other studies.32 33 We
will deliver in-person provider training as studies have
shown the value of an active approach over more passive
web-based versions,34 but we will also develop web-based
refresher trainings.
Higher intensity arm parent training
In exam rooms prior to the consultation, parents will
complete the baseline survey, view a 90 s educational
cartoon video with accompanying educational trifold
brochure and rate their desire for antibiotics via a tablet
computer. The educational video uses gain-framed
messages31 35 to explain when antibiotics are and are not
indicated while emphasising the risk of side effects and
the creation of resistant organisms. It also highlights what
information should be provided during the consultation
(eg, an estimate of illness duration, recommendations for
system relief and triggers for reconsult and contingency
plans). Parents in this arm will receive a hard copy of the
study trifold brochure.
Lower intensity intervention
This intervention will be modelled on proven parent-focused and provider-focused educational interventions
used in previous studies.19 34 36–44 Providers will complete
the same 20 min, in-person general education training
described above. Parents will receive the same parent
training described above except that parents will not
receive a hard copy of the study trifold brochure and their
antibiotic desire ratings will not be shared with providers.
Several measures will be taken to reduce the likelihood of contamination between arms. Specifically, we will
(1) train study team members to ensure that all of our
communications (written or in person) with providers in
the lower intensity arm do not reveal any of the strategies
from the higher intensity training, (2) review the importance of keeping intervention arms distinct in randomised
controlled trial designs during training, (3) directly ask
providers to pledge not to share any details of the additional communication skills training with their colleagues
randomised to the lower intensity arm, (4) control the
dissemination of the trifold brochure to ensure that only
parents who are consulted by providers in the higher
intensity arm receive them and (5) offer communication
strategies for dealing with colleagues who ask for more
information.
Data collection
Providers/administrators
At baseline, providers will complete a brief survey
collecting demographic data and providers’ views on
parent interest in antibiotics for viral illness, their
comfort with telling parents that antibiotics are not
necessary and their concern about parents’ responses.
Once parent–child dyad recruitment is complete, a brief
survey mirroring the baseline provider assessment and a
5
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Higher intensity arm provider training
Providers in this arm will receive two trainings. First, a
20 min, in-person general education training provided by
a study physician (ALM, JGN) will cover the pros and cons
of antibiotics, the impact of inappropriate use, Centers
for Disease Control and Prevention antibiotic prescribing
guidelines, common reasons for antibiotic misuse and
viewing/discussing of the parent educational cartoon
(described below). Didactic and interactive learning strategies will be employed to review the appropriate diagnostic
criteria to help distinguish a viral ARTI from a bacterial
ARTI, as well as the recommended narrow spectrum antibiotic for bacterial ARTI. Second, providers will receive a
50 min, in-person training on parent-centred communication skills provided by a behavioural psychologist (KG).
The training will use a variety of educational strategies
including viewing/discussing of motivational and role
model videos, lecture and group discussion. The goal is
to enhance providers’ confidence in use of parent-centred communication strategies (eg, open-ended questions, affirming and elicit–provide–elicit) and the study
trifold brochure to conduct key aspects of the EQUIP/
IMPACT/STAR/GRACE interventions during consultations. Specifically, they will learn to (1) elicit parents’
expectations, (2) affirm parents’ concerns, (3) provide
an evidence-based estimate of likely illness duration, (4)
provide gain-framed antibiotic information, (5) recommend options for symptom relief, (6) identify triggers for
reconsult and contingency plans and (7) elicit parents’
thoughts on the plan. Providers will also learn to use the
study trifold brochure to ensure that they complete all
necessary aspects of the intervention and provide written
notes for parents to refer to after the visit. The inside of
the study trifold brochure provides gain-framed information about when antibiotics are and are not necessary and
what risks are involved in taking antibiotics. Research has
shown that people react to the same trade-off in different
ways depending on whether the possible outcomes are
presented as losses or gains.31 In this study, we will train
providers and tailor our parent materials to highlight the
gains of not using antibiotics (eg, staying safe from side
effects, making sure that effective cures are available in
the future, knowing that their child’s body will fight off
most ARTI on its own) that may increase parents’ comfort
with not getting an antibiotic prescription for their child.
Drawing from the EQUIP study,25 the outside of the
brochure includes a place to write the child’s first name;
check boxes to indicate the diagnosis, recommended
home care treatments and reasons for reconsultation;
expected recovery time, if antibiotics are needed, and tips
for communicating with providers.
To reduce their reliance on guessing what parents want,
providers will also be trained to rely on parents’ antibiotic desire ratings taken from their baseline survey and
provided at the start of each visit via a sticky note on the
exam room door where parent–child dyads will be waiting.
To assess fidelity to the communication skills, we will
audio record a subsample of visits (10%) in both higher
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Parents
At baseline, immediately before their scheduled visit with a
provider, parents will complete a brief tablet computer-administered Research Electronic Data Capture (REDCap)
survey about their antibiotic knowledge and interest in
antibiotics for their child’s current condition. They will
then view the educational video and indicate their interest
in antibiotics for their child’s current condition again and
rate the likelihood of actually receiving antibiotics during
their visit. After meeting with their provider, parents will
complete a brief survey about their experience of the visit
including their rating of shared decision-making, satisfaction with parent–provider communication and overall
satisfaction with the visit. Two weeks later, parents will be
contacted via phone to complete a follow-up survey to
assess resolution of child’s illness, any additional healthcare visits and/or treatment, if contingency or ‘back-up’
prescriptions were filled, presence and severity of side
effects from any antibiotics administered, use of home
care treatment suggested by provider, assessment of the
educational video and brochure, and satisfaction with
study participation. Electronic medical record (EMR)
data will be abstracted using a standardised data collection form and evaluated by study physicians to determine
the appropriateness of antibiotic prescribing. Parents will
be provided with $10 per completed survey in recognition of their time and effort.
Measures
Interest in assessing patient/parent–provider communication has garnered significant attention, but measurement challenges remain. Despite a large number of
published instruments, availability of valid, reliable and

scalable measures is a recognised barrier to progress in
research and implementation of patient-centred care.45
Lack of patient involvement in scale development has
been cited as a contributing factor, so we have engaged
parent and provider stakeholders in the selection of
measures for this study. All measures have been adapted
based on their feedback, pilot testing including cognitive
debriefing was performed to ensure the briefest possible
assessment of study outcomes. All measures were translated into Spanish using standard methods and appropriate pilot testing.
Primary outcome
Antibiotic prescribing
Our primary research question is which of the two interventions leads to a lower rate of inappropriate antibiotic prescribing. We hypothesise that the rate among
providers in the higher intensity arm will be lower than
the rate produced by providers in the lower intensity
arm. If the rates do not significantly differ, we will recommend the lower intensity intervention as preferable for
dissemination as its implementation requires less time
and resources. Inappropriate prescribing will be assessed
on a weekly basis by study physicians, blinded to study
arm, who will review the medical record documentation
for each enrolled patient’s visit to determine if inappropriate antibiotic prescribing occurred. Prescriptions
will be considered inappropriate if they meet any of the
following criteria: (1) antibiotic prescribed for a viral
ARTI, (2) antibiotic prescribed for a presumed bacterial
ARTI that does not meet table 1 criteria, (3) broad-spectrum antibiotic prescribed for a bacterial ARTI in a child
without a penicillin allergy or (4) non-recommended
alternative antibiotic prescribed for a bacterial ARTI (see
table 2) in a child with a penicillin allergy.
Instead of relying on diagnostic codes as has been done
in previous studies,46 47 the study physicians will assess the
appropriateness of the patient’s diagnosis by reviewing
detailed symptoms, physical examination findings and

Table 1 Diagnostic criteria for acute respiratory tract infections (ARTIs)19 34 36 46 51
Bacterial ARTI

Diagnostic criteria

Acute otitis media
(either criteria)

1. Fever≥38.3°C (101°F) with either a or b:
a. Moderate to severe bulging of tympanic membrane on exam
b. Mild bulging of tympanic membrane and recent (<48 hours) onset of ear pain
3. New onset of otorrhoea not due to acute otitis externa
1. Daytime cough or nasal discharge for >10 days
2. High fever (>39°C) with purulent nasal discharge or facial pain lasting three consecutive days at
the beginning of the illness
3. Worsening signs or symptoms characterised by the new onset of fever, headache or increase in
nasal discharge following a typical viral upper respiratory infection

Sinusitis
(any of the three criteria)

Community-acquired
pneumonia
(either criteria)
Streptococcal pharyngitis
(both criteria)

6

1. Fever, tachypnoea and focal findings on pulmonary exam
2. (a) Fever, (b) tachypnoea, cough or retractions and (c) chest radiograph consistent with a focal
consolidation
1. Fever, pharyngitis and positive rapid streptococcal antigen test or culture
2. Lack of viral signs and symptoms

Goggin K, et al. BMJ Open 2018;8:e020981. doi:10.1136/bmjopen-2017-020981
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brief (<10 min) semistructured individual interview will
be conducted with providers and administrators to learn
about their experience of being in the study, suggestions
for improvement and ideas about disseminating to other
settings. Providers/administrators will not receive incentives for study participation.
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Bacterial acute respiratory tract
infection

Primary antibiotic

Secondary antibiotics for penicillin allergy

Acute otitis media
Community-acquired Pneumonia

Amoxicillin
Amoxicillin

Cefdinir, cefpodoxime, ceftriaxone, cefuroxime, clindamycin
Cefpodoxime, cefprozil, cefuroxime, clindamycin

Sinusitis
Streptococcal pharyngitis

Amoxicillin
Amoxicillin

Cefdinir, cefpodoxime, cefuroxime, clindamycin
Cephalexin (preferred unless previous type I hypersensitivity
reaction to penicillin) clindamycin, azithromycin

diagnostic tests in the EMR. This will guard against the
potential bias of relying on diagnostic codes alone as
clinicians sometimes match diagnostic codes to support
their antibiotic prescribing.12 Children determined to
have a bacterial infection will need documentation of
the specific diagnoses and the clinical criteria confirming
that diagnosis (listed in table 1). Ten per cent of all
chart reviews will be verified by the other study physician
blinded to the initial coding and study group. Overall
antibiotic prescription rate for different ARTI diagnoses
by arm will also be reported.
Secondary outcomes
Revisits and adverse drug reactions
We will determine if children seen by providers in
the two study arms differ in terms of revisits and/or
adverse drug reactions. Data on these clinical outcomes
will be collected via follow-up phone calls with parents
conducted 2 weeks after the visit. Parents will be asked
if any additional healthcare visits and/or treatment
occurred and, if antibiotics were given to the child, if any
side effects or adverse drug reactions occurred. Parents
will also be asked to report on when their child’s symptoms improved, if contingency prescriptions were filled,
use of home care treatment suggested by the provider,
assessment of the educational video and brochure, and
satisfaction with study participation.
Shared decision-making
We will assess parent ratings of shared decision-making
using an adapted version of the three-item CollaboRATE
questionnaire.48 This very brief (<30 s) scale was developed with input of end users and assesses the ‘effort’ that
providers put forward to initiate shared decision-making.
Members of our community advisory board and participants in several studies have strongly preferred the
CollaboRATE scale to other measures of shared decision-making, especially for more routine healthcare
issues.49 Items are: ‘How much effort was made to …
(1) help you understand your child’s health issue?; (2)
listen to the things that matter most to you about your
child’s health issues?; and (3) include what matters most
to you in choosing what to do next?’ Items are scored
on a 10-point response scale ranging from 0 ‘no effort
was made’ to 9 ‘every effort was made.’ In a simulation
study, the CollaboRATE scale demonstrated discriminative validity between six standardised patient–provider
Goggin K, et al. BMJ Open 2018;8:e020981. doi:10.1136/bmjopen-2017-020981

encounters that included varied amounts of shared decision-making, concurrent validity with other measures of
shared decision makingDM, excellent test–retest reliability and sensitivity to change.50
Quality of parent–provider communication
We will use a single item: ‘How satisfied were you with
the communication between you and your child’s
healthcare provider?’ with a five-point Likert-type
response format ranging from ‘very dissatisfied’ to ‘very
satisfied’.
Overall satisfaction with the visit
We will use a single item: ‘Overall, how satisfied were
you with the visit?’ with a five-point Likert-type response
format ranging from ‘very dissatisfied’ to ‘very satisfied’.
Data analyses
Power and sample size
Prior research examining our primary outcome has
shown that 30% of the antibiotics prescribed in the outpatient ARTI visits are inappropriate.5 Prior behavioural
intervention studies have produced 20%–81% reductions
in inappropriate prescribing,46 51 with statistically significant differences between intervention and control arms
(effect sizes: 8.3%46 and 13.1%).51 Based on the intraclass
correlation coefficient (ICC) observed in the Meeker et
al study which is most similar to our study, we assume an
ICC of .04. Assuming 30% inappropriate prescribing at
baseline and a 20% decrease in the lower intensity arm
and a conservative 50% decrease in the higher intensity
arm following intervention, with 40 providers (clusters),
α of .05 and 80% power, we will need a sample size of
760 per arm to detect a 9% difference between arms
(inappropriate antibiotic 24% in the lower intensity arm
vs 15% in the higher intensity arm after intervention).
Consistent with our historical retention rates in similar
studies in the same setting, we will protect against an attrition rate of 5% and aim to recruit 1600 participants to
ensure adequate power to assess our primary outcome
and secondary outcomes.
Planned analytic strategy
All analyses will be conducted using an intent-to-treat
strategy with available data. Initial analyses will examine
the underlying distributions of the primary and secondary
outcomes. ‘Ceiling effects’ on these measures of parent
7
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Table 2 Appropriate antibiotic selection19 36 46 51
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Missing data
All analyses will be conducted with available data. We
do not anticipate important amounts of missing data as
all data for primary outcomes are collected in a single
visit before incentives are offered and we will require
responses in the REDCap form.

Ethics and dissemination
Ethical approval was obtained from the Children’s
Mercy Hospital Pediatric Institutional Review Board
(#16060466). All participants will provide written
informed consent prior to participating in the study. We
will employ multiple strategies to protect confidentiality
of personal information about potential and enrolled
participants. Prescreening of patients will be conducted
exclusively by trained study staff on password-protected
computers and REDCap data collection tool. Appointments with potential participants will be flagged in electronic clinic scheduling systems accessible only to clinic
and study staff. Enrolled parent and patient participants
8

will complete all measures in REDCap projects, which will
only be accessible to study staff who must use multiple
passwords to access REDCap through the Children’s
Mercy network. Personal identifying information, namely
medical record number and contact information, is
marked as an identifier in REDCap and is then censored
when the database is downloaded for analysis. All identifying information will be removed with the deletion of
the REDCap project at the end of the study. Audio files
of clinic visits will be stored in a password-protected file
on the Children’s Mercy server that is only accessible to
members of the study staff. Consent forms and signature
logs for reimbursements will be secured in a locked file
cabinet within a locked office on a secured floor.
A full data package will be maintained by the investigators at Children’s Mercy Hospital for at least 7 years
after data collection is complete. Third-party access to the
full data package will be addressed by Children’s Mercy
Hospital on a case-by-case basis.
Results will be disseminated through publication in
peer-reviewed journals and conference presentations.
Study progress and findings will also be updated on c linicaltrials.gov (#NCT03037112).

Discussion
Effective parent–provider communication facilitates
rapport-building, exchange of critical information and
shared decision-making which ultimately has the potential
to reduce inappropriate antibiotic prescribing and use.
Nevertheless, efficacious and feasible training interventions that enhance effective parent–provider communication, shared decision-making and antibiotic prescribing
are lacking. This study will be the first to compare the
efficacy of two interventions directly targeting parent–
provider communication about antibiotics in the US
outpatient paediatric setting. It will also provide novel
insights about parental expectations for antibiotics
following the receipt of gain-framed information and
providers’ experience of the interventions. If successful,
the superior intervention could be widely disseminated
and potentially lead to reduced healthcare costs through
more appropriate antibiotic use, decreased additional
visits by parents who may not have felt satisfied with their
initial visit and ultimately less antibiotic resistance.
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satisfaction are not uncommon and depending on the
level of skewness, we may elect to dichotomise specific
scales. We will construct an analytic model to assess the
impact of intervention type on our primary outcome of
inappropriate antibiotic prescribing. This is a two-stage
nested design, with parents nested within providers
(level 1 units) and study site (level 2 units). Consequently,
ordinary least squares and logistic regression models are
not appropriate since the data violate the independently
and identically distributed assumption. We will use
generalised linear mixed-effect regression models using
Stata52 which allow for easy specification of both fixed
and random effects, including accommodating ≥1 cluster
variables. Alternative covariance structures will be investigated; though we hypothesise the exchangeable (or
compound symmetry) structure will suffice. We will
employ robust SEs to help minimise misspecification and
examine time as a potential random effect. The data will
be analysed using a post-test-only approach. Next, we
will examine the effects of the potential covariates (eg,
parent’s/patient’s gender, insurance type, parent’s self-reported race and ethnicity, parent’s educational attainment and provider’s years of clinical experience) on the
primary and secondary outcomes. Our goal is to identify
parsimonious final models with the fewest covariates that
best describe the outcomes.
Additionally, we will explore the heterogeneity of treatment effect or the possibility that one or both of the
interventions work better for specific groups. Variables
for consideration include language spoken at home,
language the visit was conducted in and age of child. We
will create a binary indicator for each variable and include
each as an interaction term in the regression models. We
will examine these interaction terms across intervention
arms and explore within-arm differential trends in our
primary and secondary outcomes over time.
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